1 of 1

Write now Article Tools

Since penicillin was identified in 1941 and gained consistent use as an antibiotic, resistance to treatment began to appear. Bacteria acquire DNA sequences from other bacteria that they come into contact with, sharing genes for resistance to drugs that compromise bacterial replication and survival. For example, if methicillin-resistant bacteria (such as Staphylococcus aureus) come into contact with vancomycin-resistant bacteria (such as Enterococcus faecalis), they can both potentially become double resistant to both antibiotics and replicate into a double resistant strain upon circulation. Today, only vancomycin is effective against methicillin resistant Staph strains. However, in 2002 vancomycin resistant methicillin resistant strains were identified in two U.S. states, and a third instance occurred in a long-term care facility in NY a year later. Some evidence in scientific journals indicates that the cocolonization of patients with both bacteria (Staph and Enterococci) is currently occurring, which does not bode well for the future of antibiotics.

Antibiotic-resista nt bacteria, and drug-resistant disease in general, are becoming more common as mutations allow the pathogens to survive amidst human medical advances. S. aureus usually colonizes the skin. The skin surface of a third of all people is colonized by S. aureus. Open wounds and surgical incisions can allow the bacterium to enter and gain access to the internal organs or bloodstream, leading to sepsis. Antibiotics are used to treat infections, most of which stay confined to the skin because the bacteria does not have an opportunity to spread. Methicillin-resistant S. aureus (MRSA) is usually seen in those who have invasive surgery or reduced immunity.

There are currently two types of MRSA, nosocomial, or hospital-acquired, and community, one circulating among the population. Nosocomial infections tend to be more invasive than community strains. The first community strains were seen in intravenous drug users in 1981 at the same time that MRSA was becoming rampant in hospitals, and the first deaths attributed to a community MRSA strain were four schoolchildren in Minnesota in 1997.

According to a 2007 report from the U.S. Centers for Disease Control (CDC) evaluating infection data from eight metropolitan areas in 2005, there are approximately 19,000 deaths in the U.S each year from MRSA, 15% of which are estimated to be due to a community strain. The CDC cautions that the figure may be higher than the

• 1
• 2
• next page >>

Add your voice

Know something about Vancomycin-resistant MRSA described?
We want to hear your view. Write now!